Mandate

Vinge has advised Randviken Fastigheter AB in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion.

January 03, 2022 Real Estate and Construction

Vinge has advised Randviken Fastigheter AB (publ) in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion. The acquisition was financed, inter alia, with bank facilities in an approximate amount of SEK 2.3 billion and was completed in December 2021.

The acquired properties are mainly located in Stockholm, Västerås and Malmö and the primary use is warehouse/light industrial, healthcare, school and office. The acquisition also includes a new construction project for office premises.

A significant part of the total loan amount is acquisition loans and the majority of the acquisition loans are senior loans and a smaller part is a bridge loan with a shorter maturity. The bank financing also includes a capex loan which will partly finance the completion of the new construction project.

Vinge’s team included Niclas Winnberg and Kristoffer Larson (Real Estate), as well as Fabian Ekeblad, Arvid Weimers and Elin Samara (Banking and Finance).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025